about
Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trialsWill there ever be a universal Staphylococcus aureus vaccine?Where does a Staphylococcus aureus vaccine stand?Vaccines for the 21st centuryNDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.The bicomponent pore-forming leucocidins of Staphylococcus aureusThe psmα locus regulates production of Staphylococcus aureus alpha-toxin during infectionApplying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood.Evaluation of the protective immunity of a novel subunit fusion vaccine in a murine model of systemic MRSA infection.Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infectionEfficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis.Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia modelsThe T Cell Response to Staphylococcus aureusNovel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.Biofilm matrix exoproteins induce a protective immune response against Staphylococcus aureus biofilm infection.The iron-regulated staphylococcal lipoproteins.Impact of community-associated methicillin resistant Staphylococcus aureus on HIV-infected patients.The challenge of infection prevention in spine surgery: an update.Vaccines for children and adults with chronic lung disease: efficacy against acute exacerbations.Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.Anti-Inflammatory Activity of the Essential Oil Citral in Experimental Infection with Staphylococcus aureus in a Model Air PouchElucidating the anti-Staphylococcus aureus antibody response by immunoproteomics.Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action.Combining in vitro protein detection and in vivo antibody detection identifies potential vaccine targets against Staphylococcus aureus during osteomyelitis.Th17-mediated cross protection against pneumococcal carriage by vaccination with a variable antigen.Host response to Staphylococcus aureus cytotoxins in children with cystic fibrosis.Rapid and reliable identification of Staphylococcus aureus capsular serotypes by means of artificial neural network-assisted Fourier transform infrared spectroscopy.Immunization with heat-inactivated Staphylococcus aureus induced an antibody response mediated by IgG1 and IgG2 in patients with recurrent tonsillitis.From the wound to the bench: exoproteome interplay between wound-colonizing Staphylococcus aureus strains and co-existing bacteria.Humoral immune consequences of Staphylococcus aureus ST239-associated bacteremia.Orthopaedic device-related infection: current and future interventions for improved prevention and treatment.Protective humoral and CD4+ T cellular immune responses of Staphylococcus aureus vaccine MntC in a murine peritonitis model.Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin.
P2860
Q21131308-94F2FF5C-EF3D-4EB2-8C1B-229A9BAE4A6BQ26824837-A0F707F6-BF3C-47BF-ADA8-E04E32732227Q26828726-71D2380F-255B-46AD-BA66-4674B215720EQ27007529-67456410-A001-4EA7-AF37-C70F283A7665Q30528889-BFD9652D-7F5A-4B98-8C0A-09DEB6441AC2Q33743499-F4020AE2-6019-4C5F-91BB-A05D523967D5Q34058980-F7F86949-F625-43D6-9F68-444C58972B04Q34250054-B47CA9F3-57B4-44FD-8C45-D1ED5D022871Q34545013-44EAA4F8-EE5A-461D-ADF9-40A3B3AE2350Q35063930-EDB338B8-3AA8-4198-8D85-FA198798CD32Q35880774-AFDEA889-3030-4FBE-B8A0-578699E2D369Q35887127-69EA5D0A-C5C9-4296-B3C6-42EAAC233B6CQ35887417-3E0FE399-7DBA-4467-8F39-FA1A84180FA5Q36191651-789C5856-50DF-436E-B3DE-7F3486FA87DDQ36569841-682A2AF0-3EC5-4AE2-AFA3-3D411D81EACAQ36735452-30D66659-3B8D-4390-BA8E-F3C9CCED17FFQ36970896-D3260E7F-9184-4FFB-B3D3-04270C1704C5Q37643833-07487823-B35F-486E-A2D9-84FA3BA37742Q38037549-D08E9987-395E-4B20-B034-7B076175D5C0Q38104279-20C5EE79-B903-4852-AC7D-D03CB02F1C0BQ38108232-63BDBCEA-06E6-4AFD-8D08-F0837DCD6CAFQ38168915-9B85852A-373D-472B-AE3E-9F2B073FC4A9Q38728618-379A062F-DF62-4799-B335-AF63CF304EFCQ38895531-C9155A59-DC65-46A8-A7FE-95F566B89AD7Q38924957-A3EC71F0-B57A-4BE1-921F-A5BB9FCE9394Q38967812-96651534-1CC3-472F-AF41-ED9A4CCB30D1Q39389373-00089A6A-96B4-41DB-979E-267C7570C4ACQ40119286-80CE8584-A6B3-44B1-AB07-D2890AFC0CBBQ40813839-1FB90A1E-92C3-4811-8934-769430821680Q41428438-9249A3DC-9784-4E42-BE37-AC3CC6082214Q41505557-B1002D7B-8DFD-4C5A-AF4E-FD22C05A1F0DQ46242819-A8EB546D-872A-40EF-93AF-EFF55A47EEE1Q48365132-7D8738B1-7F26-4354-B24A-BB8D2614EF25Q50893725-E9548E5D-CED8-4C80-AF5E-90218F93CC61Q53706343-B1E01AE3-D53D-46C4-A52B-B17B8051D9F5Q55030078-2F2D1112-3C9E-438B-9980-772E7F700534
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Is there a future for a Staphylococcus aureus vaccine?
@en
Is there a future for a Staphylococcus aureus vaccine?
@nl
type
label
Is there a future for a Staphylococcus aureus vaccine?
@en
Is there a future for a Staphylococcus aureus vaccine?
@nl
prefLabel
Is there a future for a Staphylococcus aureus vaccine?
@en
Is there a future for a Staphylococcus aureus vaccine?
@nl
P1433
P1476
Is there a future for a Staphylococcus aureus vaccine?
@en
P2093
Richard A Proctor
P304
P356
10.1016/J.VACCINE.2011.11.006
P407
P577
2011-11-21T00:00:00Z